AARP is a well-known company that offers supplemental health insurance for senior citizens looking to fill gaps in their Medicare coverage. The company offers eight Medicare plans through United ...
AARP/UnitedHealthcare has cheap Medicare Advantage coverage, but average plans. AARP/UnitedHealthcare is usually a good choice for Medicare Advantage plans. The company has cheap rates, a wide range ...
Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...
Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included in the historic 2022 drug law.
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
This guide provides step-by-step instructions for shopping and finding the best options for your budget and needs.
The report from AARP Public Policy Institute said average list prices on these 25 drugs have nearly doubled since they hit the market and collectively cost Medicare ‒ and American taxpayers ...
"AARP was instrumental in Congress passing the prescription drug law of 2022 to lower prices and out-of-pocket costs for Medicare enrollees and we couldn't be prouder that the day has finally ...
"Brand-name drug prices have been increasing faster than the rate of general inflation for decades, putting life-saving medications out of reach for millions of patients who need them," said Leigh ...
Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.
Most Medicare patients who hit the new $2,000 cap on out-of-pocket spending for prescription drugs could see significant savings, according to a report from AARP. The findings suggest the ...
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations, the Biden ...